Active substance: Lactose anhydrous USP, Pregelatinized starch USP, Talc USP.
Indications and usage
Management of neuropathic pain associated with diabetic peripheral neuropathy
Management of post herpetic neuralgia
Adjunctive therapy for adult patients with partial onset seizures
Pregabalin is contraindicated to known hypersensitivity to pregabalin or any of its components. Angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy.
Dosage and administration
Pregabalin is given orally with or without food. The maximum recommended dose of pregabalin is 100mg three times.
- Angioedema- can cause angioedema
- Hypersensitivity- skin redness, blisters, hives, rash, dyspnea and wheezing.
Withdrawal of Antiepileptic Drugs( AEDs)
As with all AEDs, withdraw pregabalin gradually to minimize the potential of increased seizure frequency in patients with seizure disorder.
- Suicidal Behavior and ideation- Antiepileptic drugs(AEDs) including pregabalin increase the risk of suicidal thoughts
- Peripheral edema- can cause peripheral edema
- Dizziness and Somnolence
- Weight gain- can cause weight gain
- Decreased platelet count – can lead to decreased blood platelet
Dizziness and Somnolence
Keep out of reach of childrenprotect from light and mixtureStore below 30°c in dry place